ESC 365 - Investigating the potential effect of nonsteroidal MRA use in heart failure patient care

Open Access

Investigating the potential effect of nonsteroidal MRA use in heart failure patient care

Session: Finerenone: a disease-modifying therapy for heart and kidney protection

Topic: Clinical

Speaker: Professor A. Voors (Groningen, NL) Doctor M. Kosiborod (Kansas City, US)

Sponsored by Bayer

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speakers

Professor Adriaan Voors

University Medical Centre Groningen, Groningen (Netherlands (The))

77 presentations

1 follower

Doctor Mikhail Kosiborod

St. Luke's Mid America Heart Institute, Kansas City (United States of America)

55 presentations

9 followers

4 more presentations in this session

Welcome and introductions

Speaker: Doctor M. Kosiborod (Kansas City, US)

The emerging common framework of a chronic heart-kidney disorder

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Improving kidney disease and cardiovascular outcomes with finerenone: from trials to clinical practice

Speaker: Professor G. Bakris (Chicago, US) Professor K. Marx-Schuett (Aachen, DE)

Q&A and close

Access the full session

Finerenone: a disease-modifying therapy for heart and kidney protection

Speakers: Professor A. Voors, Doctor M. Kosiborod, Doctor M. Kosiborod, Professor F. Zannad, Professor G. Bakris...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources